Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline PK/PD in Pediatric Cystic Fibrosis
NCT03771313Phase 4Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Sep 2017
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ceftaroline fosamil in cystic fibrosis (CF), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Ceftaroline Exposure and PK/PD Target Attainment at 12 hours. Started Sep 2017; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03771313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03771313.